Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05039177
Title A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies (HERKULES-3)
Acronym HERKULES-3
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Erasca, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham (O'Neal Comprehensive Cancer Center) Birmingham Alabama 35233 United States Details
City of Hope Duarte California 91010 United States Details
University of California Irvine College of Medicine Orange California 92868 United States Details
UCSF Mount Zion Medical Ctr San Francisco California 94158 United States Details
The Johns Hopkins Hospital Baltimore Maryland 21287 United States Details
Massachusetts General Hospital Boston Massachusetts 02215 United States Details
Henry Ford Cancer Institute Detroit Michigan 48202 United States Details
Washington University (Siteman Cancer Center) Saint Louis Missouri 63110 United States Details
Duke Cancer Institute Durham North Carolina 27710 United States Details
Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
Sarah Cannon Research Institute (Tennessee Oncology) Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
University of Washington - Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field